Birmingham’s Alta Innovations: the future of success

Last updated on: June 6, 2016, Author: R Sahota

We take a closer look at how Birmingham University is building a complete ecosystem for spinouts, startups and late-stage companies. One of the ambitions of James Wilkie, chief executive of Alta Innovations, has been to offer a complete package to life sciences companies from proof-of-concept through to fully independent operations.

Birmingham is particularly well-placed to achieve that goal, as Wilkie points out that within a two to three square kilometre radius there are “more than 180 registered biomedical companies and organisations”.

“Every year, there is typically more than £230m of biomedical research funding,” he says, underlining that it is not just university researchers who benefit but that there are also “the NHS clinicians and that makes a total of at least 6,000 academics”.

Full article is here:

Related Stories